KW	category	node_weight	occurrence	btw_cnt	cls_cnt	strength	qscore	Knode	ranking
abdominal pain/chemically induced	MESH	0.010752688172043	1	246.416666666667	0.386656510620683	1.01885820526487	0.304436755094195	-9.48468833585284	244
ACAD8	GENE	0.021505376344086	2	756.055555555556	0.350921103945195	1.86790670965226	0.479415609381007	6.5449753851807	80
adenocarcinoma of lung/drug therapy	MESH	0.010752688172043	1	0	0.305991562970493	0.509429102632434	0.0802306805074971	0.728045376685785	106
adrenal cortex hormones/pharmacology	MESH	0.0106382978723404	1	0	0.382949954318277	0.180753594022051	0.0187773933102653	-8.39360341512398	210
adrenal cortex hormones/therapeutic use	MESH	0.032258064516129	3	5319.64285714286	0.474352856376741	4.00980142635133	0.949665513264129	-8.77940612448914	232
adrenal gland diseases/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	7
adrenal insufficiency/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	35
AHR	GENE	0.010752688172043	1	1639.77083333333	0.422675718480947	0.679238803509912	0.217762399077278	-6.36484392147407	177
angiogenesis inhibitors/therapeutic use	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	39
anti-bacterial agents	MESH	0.0106382978723404	1	0	0.382949954318277	0.180753594022051	0.0187773933102653	-8.39360341512398	209
anti-bacterial agents/adverse effects	MESH	0.010752688172043	1	0	0.38278646728916	0.679238803509912	0.10242214532872	-8.85668561144005	235
anti-bacterial agents/pharmacology	MESH	0.010752688172043	1	820.375	0.406926041465517	1.01885820526487	0.349480968858131	-3.32734165208103	133
antibodies monoclonal humanized	MESH	0.010752688172043	1	0	0.383885605688572	0.520372995777007	0.0870588235294118	-8.72270478384899	230
antibodies monoclonal humanized/administration & dosage	MESH	0.010752688172043	1	188.25	0.30616499735222	0.84904850438739	0.213517877739331	15.8460230299144	33
antibodies monoclonal humanized/adverse effects	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	3
antibodies monoclonal humanized/therapeutic use	MESH	0.010752688172043	1	0	0.291576426805059	0.339619401754956	0.0495040369088812	-3.9143642200727	143
antibodies monoclonal/adverse effects	MESH	0.010752688172043	1	63.6527777777778	0.414840778320178	1.01885820526487	0.253179546328335	-4.00483504025976	146
antineoplastic agents immunological/adverse effects	MESH	0.075268817204301	7	7061.9	0.555145806890574	4.6042922007844	0.965013456362937	-10.3845590077811	249
antineoplastic agents immunological/therapeutic use	MESH	0.032258064516129	3	0	0.294673551694126	0.84904850438739	0.133148788927336	-6.50163031407349	179
antineoplastic agents/adverse effects	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	154
APC	GENE	0.021505376344086	2	3649.5	0.27794998980601	3.98136871449464	0.938223760092272	22.5790676362757	1
apoptosis/drug effects	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	162
ARG1	GENE	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	5
arthritis/chemically induced	MESH	0.010752688172043	1	234.514880952381	0.26493842552234	1.01885820526487	0.298223760092272	18.2813065497979	27
axitinib/administration & dosage	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	41
azoxymethane/adverse effects	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	7
b7-h1 antigen/antagonists & inhibitors	MESH	0.032258064516129	3	1003.5	0.40855029394544	1.91650389239936	0.510649750096117	-0.687750805689292	115
b7-h1 antigen/genetics	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	22
b7-h1 antigen/metabolism	MESH	0.010752688172043	1	0	0.317045817811032	0.84904850438739	0.133148788927336	-0.116108510005873	113
beclomethasone/adverse effects	MESH	0.010752688172043	1	0	0.396650996790932	0.690182696654485	0.105836216839677	-7.41476658848726	191
bevacizumab/administration & dosage	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	45
biological products/therapeutic use	MESH	0.010752688172043	1	0	0.388668711820962	0.509429102632434	0.0802306805074971	-7.82249008595613	195
biomarkers/analysis	MESH	0.010752688172043	1	142.485714285714	0.402917450915741	3.19884522667405	0.640123029603998	-6.80193787140995	186
biomarkers/metabolism	MESH	0.010752688172043	1	0	0.305991562970493	0.509429102632434	0.0802306805074971	0.728045376685785	104
BTLA	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	84
butyrates/metabolism	MESH	0.010752688172043	1	0	0.381355099216214	0.169809700877478	0.0119492502883506	-8.3815405469254	202
carcinoma non-small-cell lung	MESH	0.010752688172043	1	0	0.381833928311698	0.339619401754956	0.0495040369088812	-8.58456322914871	221
carcinoma non-small-cell lung/complications	MESH	0.010752688172043	1	708.401785714286	0.353705714573354	1.18866790614235	0.366874279123414	10.0393502556392	64
carcinoma non-small-cell lung/drug therapy	MESH	0.021505376344086	2	2676.66666666667	0.425947109785595	0.520372995777007	0.187450980392157	-1.17124415774198	117
carcinoma renal cell/drug therapy	MESH	0.021505376344086	2	273.125	0.329828552823896	2.96251050922977	0.711956939638601	12.586536894558	48
CD274	GENE	0.161290322580645	15	471	0.419849535618271	2.64177930957608	0.677816224529027	0.125180683441525	107
CD28	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	88
CD4	GENE	0.021505376344086	2	412.225	0.322394168196949	2.20015149229959	0.59921568627451	9.15933349196857	72
CD68	GENE	0.021505376344086	2	412.225	0.322394168196949	2.20015149229959	0.59921568627451	9.15933349196857	71
cd8-positive t-lymphocytes	MESH	0.010752688172043	1	0	0.381833928311698	0.339619401754956	0.0495040369088812	-8.58456322914871	220
cd8-positive t-lymphocytes/cytology	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	122
cd8-positive t-lymphocytes/drug effects	MESH	0.021505376344086	2	61.2666666666667	0.303617424602618	3.1897472921677	0.58316032295271	8.08422101729129	75
cd8-positive t-lymphocytes/immunology	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	50
CD8A	GENE	0.053763440860215	5	0	0.277601706466031	2.076824980338	0.322629757785467	10.1110556006834	62
cell line tumor	MESH	0.021505376344086	2	766	0.246565248658253	3.4719396118622	0.825528642829681	17.4206875631927	31
chemical and drug induced liver injury/diagnosis	MESH	0.010752688172043	1	0	0.381355099216214	0.169809700877478	0.0119492502883506	-8.3815405469254	203
chemokines/metabolism	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	127
CHI3L1	GENE	0.010752688172043	1	234.514880952381	0.26493842552234	1.01885820526487	0.298223760092272	18.2813065497979	28
class i phosphatidylinositol 3-kinases/antagonists & inhibitors	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	160
clostridium infections/chemically induced	MESH	0.010752688172043	1	0	0.38278646728916	0.679238803509912	0.10242214532872	-8.85668561144005	233
colitis	MESH	0.043010752688172	4	2794.5	0.48825573177101	2.50167858934444	0.730795847750865	-8.28496762133165	200
colitis collagenous/drug therapy	MESH	0.010752688172043	1	0	0.2952957381676	0.509429102632434	0.0802306805074971	3.11325557789038	97
colitis microscopic/chemically induced	MESH	0.021505376344086	2	134.5	0.42207585672639	0.585174696945077	0.139377162629758	-8.74949940177683	231
colitis ulcerative	MESH	0.010752688172043	1	0	0.381357989302329	0.169809700877478	0.0119492502883506	-8.39117503518377	205
colitis ulcerative/chemically induced	MESH	0.010752688172043	1	0	0.384985304591464	1.18866790614235	0.19118800461361	-8.59241569319228	225
colitis ulcerative/drug therapy	MESH	0.021505376344086	2	751.5	0.293826293180944	0.679238803509912	0.19838523644752	-7.6590820516937	193
colitis ulcerative/immunology	MESH	0.021505376344086	2	61.2666666666667	0.303617424602618	3.1897472921677	0.58316032295271	8.08422101729129	74
colitis ulcerative/physiopathology	MESH	0.010752688172043	1	0	0.237490073706234	0.339619401754956	0.0495040369088812	-5.42938027828002	168
colitis/chemically induced	MESH	0.741935483870968	69	32065.5	0.557014238385161	4.9988281199572	0.988235294117647	-11.0301233943529	253
colitis/diagnosis	MESH	0.021505376344086	2	60	0.334963893762607	1.18866790614235	0.266974240676663	-2.08463240019036	119
colitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	6
colitis/drug therapy	MESH	0.032258064516129	3	143	0.312538140896341	2.88676491491713	0.622560553633218	-3.35076215402916	135
colitis/epidemiology	MESH	0.010752688172043	1	0	0.360990536900771	0.509429102632434	0.0802306805074971	-1.5680767466333	118
colitis/etiology	MESH	0.021505376344086	2	3381.5	0.331745949464557	2.20752611140721	0.720461361014994	5.71017768205255	81
colitis/therapy	MESH	0.010752688172043	1	0	0.381693030472551	0.339619401754956	0.0495040369088812	-8.48752322220731	215
colon/chemistry	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	151
colon/diagnostic imaging	MESH	0.010752688172043	1	0	0.314767114661654	1.35847760701982	0.215086505190311	-3.83234320813234	137
colon/drug effects	MESH	0.032258064516129	3	865.538888888889	0.3203718614157	3.1358894841442	0.830849673202614	10.0196200723083	67
colon/immunology	MESH	0.021505376344086	2	0.5	0.421401111204731	0.754984397822555	0.108512110726644	-9.05259586616863	239
colonic neoplasms/drug therapy	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	10
colorectal neoplasms/drug therapy	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	19
crohn disease/drug therapy	MESH	0.010752688172043	1	998	0.38519905724568	0.339619401754956	0.101683967704729	-9.9361572636201	247
crohn disease/immunology	MESH	0.010752688172043	1	0	0.271026809525815	1.35847760701982	0.215086505190311	10.6374701144874	60
crohn disease/physiopathology	MESH	0.010752688172043	1	0	0.237490073706234	0.339619401754956	0.0495040369088812	-5.42938027828002	167
CRP	GENE	0.010752688172043	1	708.401785714286	0.353705714573354	1.18866790614235	0.366874279123414	10.0393502556392	63
CSF2	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	82
ctla-4 antigen/antagonists & inhibitors	MESH	0.032258064516129	3	1184.71111111111	0.450011022039758	2.73840398522122	0.820607458669742	-4.92092496693007	163
ctla-4 antigen/immunology	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	130
CTLA4	GENE	0.129032258064516	12	1039	0.41985697913095	3.47245798616776	0.866589773164168	0.0404147424443596	111
CXCL10	GENE	0.010752688172043	1	0	0.355134754389975	1.01885820526487	0.172410611303345	-6.56906887632758	180
CXCL8	GENE	0.010752688172043	1	234.514880952381	0.26493842552234	1.01885820526487	0.298223760092272	18.2813065497979	25
CXCL9	GENE	0.010752688172043	1	0	0.355134754389975	1.01885820526487	0.172410611303345	-6.56906887632758	185
cytomegalovirus infections/complications	MESH	0.010752688172043	1	0	0.381357989302329	0.169809700877478	0.0119492502883506	-8.39117503518377	206
cytomegalovirus infections/diagnosis	MESH	0.010752688172043	1	0	0.380481251103793	0.169809700877478	0.0119492502883506	-7.96962509193747	198
cytotoxicity immunologic	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	53
dermatitis	MESH	0.010752688172043	1	0	0.355134754389975	1.01885820526487	0.172410611303345	-6.56906887632758	184
dextran sulfate/adverse effects	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	11
diabetes mellitus type 1/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	38
diarrhea	MESH	0.021505376344086	2	0	0.432887049137734	1.34015909476763	0.192895040369089	-8.67973778966799	227
diarrhea/chemically induced	MESH	0.150537634408602	14	5478.27857142857	0.539914945773741	2.76301147172498	0.884567474048443	-10.2919842434836	248
diarrhea/therapy	MESH	0.010752688172043	1	77.45	0.391184786462419	0.509429102632434	0.122875816993464	-7.94187463095341	196
disease progression	MESH	0.010752688172043	1	246.416666666667	0.386656510620683	1.01885820526487	0.304436755094195	-9.48468833585284	243
disease susceptibility	MESH	0.010752688172043	1	67.3333333333333	0.388170226304072	0.509429102632434	0.121430219146482	-9.45638343233258	240
dose-response relationship drug	MESH	0.021505376344086	2	207	0.34206780807242	1.01885820526487	0.278031526336025	7.57473358689567	76
drug resistance/immunology	MESH	0.010752688172043	1	0	0.314767114661654	1.35847760701982	0.215086505190311	-3.83234320813234	138
drug synergism	MESH	0.021505376344086	2	766	0.246565248658253	3.4719396118622	0.825528642829681	17.4206875631927	30
drug-related side effects and adverse reactions	MESH	0.021505376344086	2	2826.1	0.405999125662436	1.5282873078973	0.492933487120338	-0.896141176352434	116
drug-related side effects and adverse reactions/diagnosis	MESH	0.010752688172043	1	0	0.381334325088198	0.339619401754956	0.0495040369088812	-8.24983960027208	199
drug-related side effects and adverse reactions/prevention & control	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	49
drugs investigational/administration & dosage	MESH	0.010752688172043	1	188.25	0.30616499735222	0.84904850438739	0.213517877739331	15.8460230299144	32
dysbiosis/etiology	MESH	0.010752688172043	1	820.375	0.406926041465517	1.01885820526487	0.349480968858131	-3.32734165208103	132
encephalitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	10
endometrial neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.383885605688572	0.520372995777007	0.0870588235294118	-8.72270478384899	228
enterocolitis/chemically induced	MESH	0.021505376344086	2	502.833333333333	0.295242265301917	1.18866790614235	0.356539792387543	-6.89066972301344	187
escherichia coli infections/drug therapy	MESH	0.010752688172043	1	0	0.38278646728916	0.679238803509912	0.10242214532872	-8.85668561144005	234
esophagitis	MESH	0.010752688172043	1	0	0.381833928311698	0.339619401754956	0.0495040369088812	-8.58456322914871	219
exanthema/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	46
fatigue/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	44
feces	MESH	0.010752688172043	1	285.516666666667	0.403394921018897	0.509429102632434	0.143114186851211	-3.94676901655992	145
feces/chemistry	MESH	0.010752688172043	1	15.4857142857143	0.395203367762973	0.84904850438739	0.141545559400231	-7.22048274751933	189
gastritis/chemically induced	MESH	0.0106382978723404	1	0	0.382949954318277	0.180753594022051	0.0187773933102653	-8.39360341512398	208
gastritis/complications	MESH	0.010752688172043	1	246.416666666667	0.386656510620683	1.01885820526487	0.304436755094195	-9.48468833585284	242
gastrointestinal neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	86
gastrointestinal tract/metabolism	MESH	0.010752688172043	1	0	0.317045817811032	0.84904850438739	0.133148788927336	-0.116108510005873	114
gene expression regulation neoplastic	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	14
gene expression regulation/genetics	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	126
gentian violet	MESH	0.010752688172043	1	0	1.20454310422196	0.169809700877478	1	0	2
glucocorticoids	MESH	0.010752688172043	1	234.514880952381	0.26493842552234	1.01885820526487	0.298223760092272	18.2813065497979	26
glucocorticoids/pharmacology	MESH	0.010752688172043	1	0	0.314767114661654	1.35847760701982	0.215086505190311	-3.83234320813234	141
glucocorticoids/therapeutic use	MESH	0.010752688172043	1	246.416666666667	0.386656510620683	1.01885820526487	0.304436755094195	-9.48468833585284	245
glycoproteins/metabolism	MESH	0.010752688172043	1	0	0.305991562970493	0.509429102632434	0.0802306805074971	0.728045376685785	105
graft vs host disease/immunology	MESH	0.010752688172043	1	0	0.271026809525815	1.35847760701982	0.215086505190311	10.6374701144874	59
growth inhibitors/therapeutic use	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	51
hashimoto disease/chemically induced	MESH	0.010752688172043	1	0	0.384985304591464	1.18866790614235	0.19118800461361	-8.59241569319228	226
HAVCR2	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	90
hepatitis autoimmune/etiology	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	37
hepatitis/diagnosis	MESH	0.010752688172043	1	0	0.381355099216214	0.169809700877478	0.0119492502883506	-8.3815405469254	204
hepatitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	9
host microbial interactions/drug effects	MESH	0.010752688172043	1	820.375	0.406926041465517	1.01885820526487	0.349480968858131	-3.32734165208103	134
ht29 cells	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	21
hypophysitis/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	36
IL15	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	89
IL17A	GENE	0.021505376344086	2	652	0.232960097366497	2.54714551316217	0.678185313341023	20.558157223237	23
IL17C	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	92
IL21	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	83
IL22	GENE	0.021505376344086	2	3161.35714285714	0.353099063692349	2.55808940630674	0.79598615916955	2.03644639726148	99
IL4	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	91
IL6	GENE	0.021505376344086	2	1395.55952380952	0.30038742029721	2.72789910718422	0.820561322568243	9.30020186090555	70
immune checkpoint inhibitors	MESH	0.32258064516129	30	19598.8	0.557014238385081	6.9071251487983	0.992156862745098	-11.0374613221987	254
immune checkpoint inhibitors/administration & dosage	MESH	0.043010752688172	4	3440.10714285714	0.309831617204146	1.60403290220994	0.504882737408689	19.5097073026506	24
immune checkpoint inhibitors/adverse effects	MESH	0.56989247311828	53	20716.875	0.557014238385161	4.71176166376074	0.980453671664744	-10.9995456101895	252
immune checkpoint inhibitors/pharmacology	MESH	0.043010752688172	4	1555.33492063492	0.364468499318533	2.55808940630674	0.766505190311419	1.61991967659201	100
immune checkpoint inhibitors/therapeutic use	MESH	0.021505376344086	2	0	0.226722974878454	1.35847760701982	0.215086505190311	9.95506607936706	68
immune system diseases/drug therapy	MESH	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	85
immunocompromised host	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	4
immunologic factors	MESH	0.021505376344086	2	0	0.420996293782011	0.585174696945077	0.0904728950403691	-8.87965783958228	237
immunologic memory/drug effects	MESH	0.010752688172043	1	319.5	0.350595607043297	1.35847760701982	0.387543252595156	1.4186679830503	102
immunosuppressive agents/pharmacology	MESH	0.010752688172043	1	0	0.314767114661654	1.35847760701982	0.215086505190311	-3.83234320813234	140
immunosuppressive agents/therapeutic use	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	5
inflammation	MESH	0.010752688172043	1	0	1.20454310422196	0.169809700877478	1	0	1
inflammation/drug therapy	MESH	0.021505376344086	2	2534.72619047619	0.351384633031582	2.37733581228469	0.717385620915033	-4.94316365648272	164
inflammatory bowel diseases	MESH	0.021505376344086	2	713	0.390012722384539	1.5282873078973	0.437708573625529	-3.46398675669799	136
inflammatory bowel diseases/complications	MESH	0.021505376344086	2	4	0.35675513707478	0.773808253414722	0.112202998846597	2.74688945194679	98
inflammatory bowel diseases/drug therapy	MESH	0.032258064516129	3	1946.25	0.401198754974998	1.43422320133247	0.473817762399077	4.80325100691023	94
infliximab/administration & dosage	MESH	0.010752688172043	1	708.401785714286	0.353705714573354	1.18866790614235	0.366874279123414	10.0393502556392	66
infliximab/adverse effects	MESH	0.043010752688172	4	753.5	0.383732921687181	2.63383500061939	0.714156093810073	-5.71780342136177	169
interferon-gamma/metabolism	MESH	0.010752688172043	1	319.5	0.350595607043297	1.35847760701982	0.387543252595156	1.4186679830503	101
interleukin-12/antagonists & inhibitors	MESH	0.010752688172043	1	0	0.236756084102884	0.509429102632434	0.0802306805074971	-6.33430294993455	174
interleukin-17/genetics	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	18
interleukin-23/antagonists & inhibitors	MESH	0.010752688172043	1	0	0.236756084102884	0.509429102632434	0.0802306805074971	-6.33430294993455	173
intestinal mucosa/chemistry	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	153
intestinal mucosa/diagnostic imaging	MESH	0.010752688172043	1	0	0.314767114661654	1.35847760701982	0.215086505190311	-3.83234320813234	142
intestinal mucosa/immunology	MESH	0.010752688172043	1	0	0.381690135306068	0.339619401754956	0.0495040369088812	-8.46741891464867	213
ipilimumab/adverse effects	MESH	0.0967741935483871	9	1.5	0.556744049014034	2.32842038694957	0.338869665513264	-10.8717152470119	250
ipilimumab/therapeutic use	MESH	0.032258064516129	3	500.125	0.361347023419876	3.54768520617485	0.779331026528258	10.98561997138	58
leukemia lymphocytic chronic b-cell/drug therapy	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	161
leukocyte l1 antigen complex/analysis	MESH	0.010752688172043	1	15.4857142857143	0.395203367762973	0.84904850438739	0.141545559400231	-7.22048274751933	190
LIF	GENE	0.010752688172043	1	0	0.285712710270411	2.03771641052974	0.320922722029989	5.00558069970135	87
ligands	MESH	0.010752688172043	1	0	0.348218465041475	0.339619401754956	0.0495040369088812	-5.36321720144016	166
LTF	GENE	0.010752688172043	1	0	0.396492248882852	0.690182696654485	0.105836216839677	-8.42451919509856	211
lung neoplasms	MESH	0.010752688172043	1	163.4	0.388465456057213	0.339619401754956	0.07760092272203	-8.57023124805898	217
lung neoplasms/drug therapy	MESH	0.021505376344086	2	0	0.381809563235149	0.339619401754956	0.0495040369088812	-8.46437031485098	212
lymphocytes tumor-infiltrating/immunology	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	54
lymphocytes tumor-infiltrating/metabolism	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	17
lymphocytes/drug effects	MESH	0.010752688172043	1	63.6527777777778	0.414840778320178	1.01885820526487	0.253179546328335	-4.00483504025976	149
lymphocytosis/chemically induced	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	158
lymphoma non-hodgkin/drug therapy	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	159
macrophages/drug effects	MESH	0.010752688172043	1	0	0.271026809525815	1.35847760701982	0.215086505190311	10.6374701144874	61
melanoma/complications	MESH	0.032258064516129	3	775.379365079365	0.369975701514306	2.21847000455179	0.655947712418301	4.27814574331199	95
melanoma/drug therapy	MESH	0.053763440860215	5	1162.6	0.408678369662675	2.7743822961001	0.824175317185698	-6.08318496801502	172
melanoma/genetics	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	120
melanoma/immunology	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	6
mesalamine/pharmacology	MESH	0.010752688172043	1	64.7444444444444	0.307873846522319	0.84904850438739	0.199123414071511	7.13262370817954	77
metabolome/drug effects	MESH	0.010752688172043	1	820.375	0.406926041465517	1.01885820526487	0.349480968858131	-3.32734165208103	131
micrornas/genetics	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	13
MIR15B	GENE	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	15
MTOR	GENE	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	52
mucositis/chemically induced	MESH	0.010752688172043	1	0	0.314767114661654	1.35847760701982	0.215086505190311	-3.83234320813234	139
multigene family	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	124
myasthenia gravis/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	40
myasthenia gravis/diagnosis	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	1
mycophenolic acid	MESH	0.0106382978723404	1	0	0.382949954318277	0.180753594022051	0.0187773933102653	-8.39360341512398	207
myeloid cells/cytology	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	128
myeloid-derived suppressor cells/metabolism	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	6
myocarditis/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	43
myocarditis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	5
neoplasm recurrence local/drug therapy	MESH	0.010752688172043	1	0	0.383885605688572	0.520372995777007	0.0870588235294118	-8.72270478384899	229
neoplasms	MESH	0.043010752688172	4	62	0.436882768522483	1.43422320133247	0.312987312572088	-9.69609783407763	246
neoplasms/complications	MESH	0.032258064516129	3	323	0.334971740230258	1.35847760701982	0.389480968858131	4.96344865318853	93
neoplasms/diagnosis	MESH	0.010752688172043	1	188.25	0.30616499735222	0.84904850438739	0.213517877739331	15.8460230299144	34
neoplasms/diagnostic imaging	MESH	0.021505376344086	2	0	1.20454310422196	1.69809700877478	1	0	8
neoplasms/drug therapy	MESH	0.129032258064516	12	12776.8869047619	0.557008072773487	6.73370479221127	0.984359861591696	-11.0648536932457	255
neoplasms/therapy	MESH	0.010752688172043	1	77.45	0.391184786462419	0.509429102632434	0.122875816993464	-7.94187463095341	197
nephritis/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	47
neutrophils/drug effects	MESH	0.010752688172043	1	63.6527777777778	0.414840778320178	1.01885820526487	0.253179546328335	-4.00483504025976	147
nivolumab/adverse effects	MESH	0.129032258064516	12	4860.16666666667	0.556962389594733	5.20704312164214	0.961030372933487	-10.9673373387132	251
nivolumab/therapeutic use	MESH	0.021505376344086	2	537.642857142857	0.261099558819956	2.88676491491713	0.748512110726644	18.0290011850941	29
NRF1	GENE	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	16
oropharyngeal neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.381333684925961	0.169809700877478	0.0119492502883506	-8.29664790553899	201
paclitaxel/therapeutic use	MESH	0.010752688172043	1	0	0.384985304591464	1.18866790614235	0.19118800461361	-8.59241569319228	224
pancreatitis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	2
PARP1	GENE	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	4
PDCD1	GENE	0.268817204301075	25	752.5	0.419849861273493	2.43413277215915	0.65439446366782	0.102546222647234	110
pericarditis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	11
phenotype	MESH	0.021505376344086	2	61.2666666666667	0.303617424602618	3.1897472921677	0.58559015763168	8.08472604175398	73
phosphatidylinositol 3-kinases/metabolism	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	56
phthalazines/administration & dosage	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	2
PIK3CD	GENE	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	152
piperazines/administration & dosage	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	8
piperidines/therapeutic use	MESH	0.021505376344086	2	7.5	0.312919396431653	1.43422320133247	0.231910803537101	0.105412651360932	108
pneumonia	MESH	0.010752688172043	1	0	0.348218465041475	0.339619401754956	0.0495040369088812	-5.36321720144016	165
pneumonia/chemically induced	MESH	0.032258064516129	3	3023.72619047619	0.362207096651424	3.61421022274165	0.919246443675509	11.1910941357691	57
pneumonia/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	4
poly(adp-ribose) polymerase inhibitors/administration & dosage	MESH	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	9
postoperative complications	MESH	0.010752688172043	1	67.3333333333333	0.388170226304072	0.509429102632434	0.121430219146482	-9.45638343233258	241
prednisolone/therapeutic use	MESH	0.010752688172043	1	0	0.381838206341825	0.509429102632434	0.0802306805074971	-8.54240352509853	216
prednisone/therapeutic use	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	2
programmed cell death 1 receptor/antagonists & inhibitors	MESH	0.086021505376344	8	831.5	0.477116881969058	1.88935548083383	0.500484429065744	-7.66802278377252	194
programmed cell death 1 receptor/metabolism	MESH	0.010752688172043	1	0	0.317045817811032	0.84904850438739	0.133148788927336	-0.116108510005873	112
protective agents/pharmacology	MESH	0.010752688172043	1	64.7444444444444	0.307873846522319	0.84904850438739	0.199123414071511	7.13262370817954	78
protein kinase inhibitors/adverse effects	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	156
protein kinase inhibitors/therapeutic use	MESH	0.010752688172043	1	370.833333333333	0.390610695259917	0.84904850438739	0.242306805074971	-7.08901425586623	188
proton pump inhibitors/adverse effects	MESH	0.010752688172043	1	0	0.317398403888825	0.509429102632434	0.0802306805074971	9.68160798982919	69
pruritus/chemically induced	MESH	0.010752688172043	1	26.485347985348	0.301503201668335	2.72789910718422	0.461345636293733	15.0260458058822	42
psoriasis	MESH	0.010752688172043	1	0	0.355134754389975	1.01885820526487	0.172410611303345	-6.56906887632758	182
purines/adverse effects	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	157
pyrimidines/therapeutic use	MESH	0.021505376344086	2	7.5	0.312919396431653	1.43422320133247	0.228342945021146	0.104671096453695	109
quinazolinones/adverse effects	MESH	0.0106382978723404	1	0	0.351323002357104	2.53055031630871	0.358477508650519	-4.62166088108843	155
receptors antigen t-cell/genetics	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	125
receptors cxcr3/genetics	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	121
receptors cxcr6/genetics	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	123
recurrence	MESH	0.010752688172043	1	178	0.375563506699277	3.02903552579657	0.635140330642061	-4.4334468875057	150
rna	MESH	0.010752688172043	1	0	0.355134754389975	1.01885820526487	0.172410611303345	-6.56906887632758	183
sarcoidosis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	1
sirolimus/therapeutic use	MESH	0.010752688172043	1	223.1875	0.277267417758969	1.86790670965226	0.413440984236832	11.273565396564	55
skin neoplasms/complications	MESH	0.010752688172043	1	0	0.2952957381676	0.509429102632434	0.0802306805074971	3.11325557789038	96
skin neoplasms/drug therapy	MESH	0.021505376344086	2	207.5	0.377206656651912	2.28327170571986	0.537024221453287	-5.98090543296499	171
skin neoplasms/immunology	MESH	0.010752688172043	1	0	1.20454310422196	1.01885820526487	1	0	7
SNCA	GENE	0.032258064516129	3	40	0.369344040857368	1.5282873078973	0.294532871972318	-6.38322841517941	178
squamous cell carcinoma of head and neck/drug therapy	MESH	0.010752688172043	1	0	0.384985304591464	1.18866790614235	0.19118800461361	-8.59241569319228	222
steroids/adverse effects	MESH	0.010752688172043	1	0	0.291576426805059	0.339619401754956	0.0495040369088812	-3.9143642200727	144
steroids/therapeutic use	MESH	0.021505376344086	2	28	0.324871508530995	0.509429102632434	0.0954094579008074	1.00573659467027	103
t-lymphocyte subsets/immunology	MESH	0.010752688172043	1	0	0.381690135306068	0.339619401754956	0.0495040369088812	-8.46741891464867	214
t-lymphocytes cytotoxic/immunology	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	20
t-lymphocytes regulatory/cytology	MESH	0.010752688172043	1	0	0.276439975798376	2.03771641052974	0.320922722029989	-2.4020581930382	129
TCIM	GENE	0.010752688172043	1	0	0.355134754389975	1.01885820526487	0.172410611303345	-6.56906887632758	181
thyroiditis/diagnostic imaging	MESH	0.010752688172043	1	0	1.20454310422196	1.69809700877478	1	0	3
TIPARP	GENE	0.010752688172043	1	44.3000000000001	0.237326013203866	2.03771641052974	0.445244136870434	22.1922486995436	3
TNF	GENE	0.032258064516129	3	5675	0.498690179672051	3.11611569168628	0.91118800461361	-8.89371378500065	238
tongue neoplasms/drug therapy	MESH	0.010752688172043	1	0	0.384985304591464	1.18866790614235	0.19118800461361	-8.59241569319228	223
trinitrobenzenesulfonic acid/adverse effects	MESH	0.010752688172043	1	64.7444444444444	0.307873846522319	0.84904850438739	0.199123414071511	7.13262370817954	79
tryptophan/pharmacology	MESH	0.010752688172043	1	1639.77083333333	0.422675718480947	0.679238803509912	0.217762399077278	-6.36484392147407	176
tumor microenvironment/drug effects	MESH	0.010752688172043	1	30.5454545454545	0.236158849634789	2.03771641052974	0.413440984236832	21.4801140523686	12
tumor necrosis factor inhibitors	MESH	0.010752688172043	1	0	0.36800396315235	0.84904850438739	0.133148788927336	-5.75373052844998	170
ulcer/chemically induced	MESH	0.010752688172043	1	0	0.381833928311698	0.339619401754956	0.0495040369088812	-8.58456322914871	218
urothelium/drug effects	MESH	0.010752688172043	1	708.401785714286	0.353705714573354	1.18866790614235	0.366874279123414	10.0393502556392	65
ustekinumab/therapeutic use	MESH	0.010752688172043	1	0	0.236756084102884	0.509429102632434	0.0802306805074971	-6.33430294993455	175
virus diseases/etiology	MESH	0.010752688172043	1	0	0.38278646728916	0.679238803509912	0.10242214532872	-8.85668561144005	236
vitamin d	MESH	0.010752688172043	1	0	0.39140610324029	0.339619401754956	0.0495040369088812	-7.52820644779071	192
vitamin d/administration & dosage	MESH	0.010752688172043	1	63.6527777777778	0.414840778320178	1.01885820526487	0.253179546328335	-4.00483504025976	148
